SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-039174
Filing Date
2021-03-19
Accepted
2021-03-19 17:04:28
Documents
1
Period of Report
2021-03-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm219870-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm219870-4_4seq1.xml 4 23077
  Complete submission text file 0001104659-21-039174.txt   24475
Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Issuer) CIK: 0001467652 (see all company filings)

IRS No.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 4819 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address
Eisenstadt Richard I (Reporting) CIK: 0001515806 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37508 | Film No.: 21758976